Abstract:A potent natural combretastatin, combretastatin A-4 ( COMA4 ) targets the condylon active pocket to produce anticancer effects. Studies on inflammation and oxidative stress have been linked to cancer, indicating that lowering these risk variables may have an adverse effect on the progression of cancer. This study utilized COMA4 as a building block to create 28 coumarins with improved therapeutic effects. The first coumarin derivative, COMA4-COU-1 , was activated by thionyl chloride and then coupled with various phenols, resulting in 27 COMA4-COU derivatives. Biomedical-related activities were conducted using COMA4 as a reference, including anticancer activity assayed against eight cancerous cellular populations, antioxidant activity evaluated on H 2 O 2 -treated human SH-SY5Y populations, and anti-inflammatory activity tested against three enzymatic mediators of inflammation. The biosafety studies included testing the effects of COMA4 and its coumarins on the normal growth of three cell populations and on human erythrocyte hemolysis. Finally, the pharmacokinetic indexes of the building block and its derivatives were computerized using two web-based programs. The results indicated that the biomedical activities are directly improved by the presence of an electron-donating group on the off-side aromatic ring. Also, these activities were increased when this group substituted at the para or meta position. The maximum activities were revealed when this aromatic ring was trisubstituted with this group type, with privilege activities for the trimethoxy aromatic ring. Concerning the biocompatibility studies, the synthetic coumarins demonstrated a high level of compatibility with the tested normal cells and also with human erythrocytes. Moreover, the in silico analysis demonstrated the capacity of the synthetic coumarins to present potential drug candidates. The author concluded that the coumarin-structural modification can open the door for developing new, potent, and biosafe COMA4 derivatives. In this regard, this study afforded many insights about the structure–function relationships of the synthesized compounds that can guide future research about COMA4 -based derivatives.

Practical and Green Synthesis of Combretastatin A-4 and Its Prodrug Ca4p Using Renewable Biomass-Based Starting Materials

MICROSYNTHESIS OF A NOVEL HERBICIDE, PROPYL 4-[ 2-[ (4,6-DIMETHOXY-2-PYRIMIDINYL) OXY] BENZYLAMINO] BENZOATE

Synthesis, in vitro, and in vivo evaluation of phosphate ester derivatives of combretastatin A-4

Development of Combretastatin A-4 Analogues as Potential Anticancer Agents with Improved Aqueous Solubility

Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy

Water-Soluble Combretastatin A4 Phosphate Orally Delivered Via Composite Nanoparticles with Improved Inhibition Effect Toward S180 Tumors.

Ultrasound-promoted two-step synthesis of 3-arylselenylindoles and 3-arylthioindoles as novel combretastatin A-4 analogues

Synthesis of a New Antihyperlipidaemic Agent-Simvastatin

An environmentally benign protocol for aqueous synthesis of tetrahydrobenzo[b]pyrans catalyzed by cost-effective ionic liquid.

An Efficient Procedure for the Preparation of Natural Products Bearing the 2-(2-phenylethyl)chromone Skeleton

Synthesis And In Vitro Antitumor Activities Of 3,4-Diaryl Substituted Pyrrolones Derivatives

An Environmentally Benign Protocol for Aqueous Synthesis of Tetrahydrobenzo[b]Pyrans Catalyzed by Cost-Effective Ionic Liquid

An Efficient and Eco‐Friendly Synthesis of Protoberberine and 13‐Me Protoberberine Alkaloids via Electrochemical Acceptorless Dehydrogenation

Synthesis andin vitroAntitumor Activities of 3,4-Diaryl Substituted Pyrrolones Derivatives

Direct synthesis of alkylated 4-hydroxycoumarin derivatives via a cascade Cu-catalyzed dehydrogenation/conjugate addition sequence

Design, synthesis of combretastatin A-4 piperazine derivatives as potential antitumor agents by inhibiting tubulin polymerization and inducing autophagy in HCT116 cells

Total Syntheses of (+)‐sarcophytin, (+)‐chatancin, (−)‐3‐oxochatancin, and (−)‐pavidolide B: A Divergent Approach

Combretastatin A4-based coumarins: synthesis, anticancer, oxidative stress-relieving, anti-inflammatory, biosafety, and in silico analysis

Design, Synthesis, Biological Evaluation and Cocrystal Structures with Tubulin of Chiral Β-Lactam Bridged Combretastatin A-4 Analogues As Potent Antitumor Agents.

Design, Synthesis, And Biological Evaluation Of Hydantoin Bridged Analogues Of Combretastatin A-4 As Potential Anticancer Agents

Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity